Balance Improves with Exercise in Patients with Multiple Sclerosis

Specific exercises may help to improve balance for patients with multiple sclerosis (MS), according to a new study published by Neurology.
 
Patients with MS may experience a host of adverse events that correlate with the part of the nervous system damaged. Patients may experience balance and movement issues related to damage of the cerebellum and brainstem, which control signals from systems of the body including sensory, visual, and inner ear. This damage may cause patients to fall and injure themselves.
 
In the new study, the authors explored the efficacy of a vestibular rehabilitation program called Balance and Eye-Movement Exercises for People with MS (BEEMS).
 
Included in the trial were 88 patients with MS who were able to walk 100 meters using a walking device. Patients underwent assessments that quantified balance, fatigue, cognition, dizziness, and quality of life. Neurologists evaluated MRI scans to determine disease activity in the cerebellum or brainstem.
 
Patients were randomized into 1 of 2 cohorts: one group completed supervised exercises twice per week and were given instructions to exercise every day at home for 6 weeks. These individuals then completed 1 supervised exercise session plus daily exercises at home for 8 weeks. The second group was placed on a waiting list.
 
The BEEMS program included activities such as balancing on different surfaces, walking with and without head movements and with eyes open and closed, and eye movement exercises.
 
The authors noted that the assessment at 6 weeks showed that patients in the BEEMS cohort had significantly improved measures of balance compared with patients in the control group, according to the study.
 
Additionally, patients in the exercise group had improvements in fatigue, cognition, dizziness, and quality of life.
 
These improvements were found to persist through 14 weeks, according to the study.
 
The authors found that the improvements at 6 weeks were even more profound among BEEMS patients who previously had MS-related damage to the cerebellum or brainstem; however, these results did not remain true at 14 weeks, according to the study.
 
“BEEMS improved multiple outcomes regardless of whether brainstem/cerebellar lesions were present, supporting the generalizability of BEEMS for ambulatory people with MS who have at least minimally impaired balance and fatigue,” the authors wrote.
 
The researchers plan to confirm the benefits of the BEEMS study for patients with MS. Further studies should also determine how long the improvements last and the requirement of supervised exercise, according to the study. The authors hypothesize that telehealth platforms may be able to provide a cost-effective, long-term solution for delivering the program.
 
The authors concluded that patients who wish to start balance and eye movement exercises should consult with their physician. 


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

An HIV primary care program is working to reduce the number of new HIV diagnoses and increase viral suppression rates in Long Island and Queens.
Fingolimod (Gilenya, Novartis) is the first FDA-approved treatment to treat multiple sclerosis in pediatric patients.
ALS is a progressive disease in which the motor neurons eventually die, and mortality is usually the result of respiratory failure. Currently, there is no cure for ALS. However, in the last decade advances have been made in both discovery and research that are promising. As new therapies enter the forefront of ALS care, a multitude of healthcare professionals will need to understand more about the disease state, therapy, and their role within ALS care. This activity will explain the impact of amyotrophic lateral sclerosis (ALS) and the value of early diagnosis; examine recent ALS therapy advances, including the efficacy and mechanism of action of new agents; analyze the implications of ALS therapy in the managed care setting; and distinguish the need for integrations among physicians and specialty and managed care pharmacists in the coordination of care for patients with ALS.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.